Efficacy of Racecadotril in the Management of Acute Gastroenteritis in Childre
Not Applicable
- Conditions
- Acute Gastroenteritis.
- Registration Number
- IRCT20221231056999N4
- Lead Sponsor
- Rai Medical College, Sargodha, Pakistan
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- 42
Inclusion Criteria
Children of both genders
Aged between 1 to 18 years
Presenting with acute gastroenteritis and some dehydration
Exclusion Criteria
Children with malnutrition
Osmotic diarrhea
Chronic diarrhea
Bloody diarrhea
Immunocompromised children
Severe dehydration
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Reduction in number of stools. Timepoint: 3 days. Method of measurement: Parents or guardians of the studied children will be telephonically contacted and asked about the number of stools per day after 3 days of treatment.
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What is the molecular mechanism of Racecadotril in reducing diarrhea in acute gastroenteritis in children?
How does Racecadotril compare to standard-of-care treatments like ORT in managing acute gastroenteritis in children?
Are there specific biomarkers that predict treatment response to Racecadotril in pediatric acute gastroenteritis patients?
What are the potential adverse events of Racecadotril in children with acute gastroenteritis and their management strategies?
What other enkephalinase inhibitors are being studied for acute gastroenteritis in children alongside Racecadotril?